HSBC Holdings’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $73.7K | Buy |
42,697
+26,463
| +163% | +$45.6K | ﹤0.01% | 2420 |
|
|
2025
Q1 | $53.2K | Sell |
16,234
-15,711
| -49% | -$51.5K | ﹤0.01% | 2441 |
|
|
2024
Q4 | $232K | Buy |
31,945
+14,045
| +78% | +$102K | ﹤0.01% | 2222 |
|
|
2024
Q3 | $172K | Buy |
+17,900
| New | +$172K | ﹤0.01% | 2294 |
|
|
2024
Q2 | – | Sell |
-24,644
| Closed | -$365K | – | 2628 |
|
|
2024
Q1 | $365K | Buy |
+24,644
| New | +$365K | ﹤0.01% | 1896 |
|
|
2022
Q3 | – | Sell |
-10,744
| Closed | -$118K | – | 2609 |
|
|
2022
Q2 | $118K | Buy |
+10,744
| New | +$118K | ﹤0.01% | 2578 |
|
|
2021
Q4 | – | Sell |
-9,345
| Closed | -$231K | – | 2784 |
|
|
2021
Q3 | $231K | Sell |
9,345
-2,138
| -19% | -$52.8K | ﹤0.01% | 2238 |
|
|
2021
Q2 | $303K | Buy |
+11,483
| New | +$303K | ﹤0.01% | 2088 |
|
|
2021
Q1 | – | Sell |
-5,777
| Closed | -$271K | – | 2466 |
|
|
2020
Q4 | $271K | Sell |
5,777
-6,288
| -52% | -$295K | ﹤0.01% | 2200 |
|
|
2020
Q3 | $400K | Buy |
12,065
+3,372
| +39% | +$112K | ﹤0.01% | 1674 |
|
|
2020
Q2 | $239K | Buy |
+8,693
| New | +$239K | ﹤0.01% | 1869 |
|